Rhythm Pharmaceuticals, Inc. (RYTM)
NASDAQ: RYTM · Real-Time Price · USD
58.89
-0.47 (-0.79%)
Nov 21, 2024, 11:23 AM EST - Market open
Rhythm Pharmaceuticals Employees
Rhythm Pharmaceuticals had 226 employees as of December 31, 2023. The number of employees increased by 49 or 27.68% compared to the previous year.
Employees
226
Change (1Y)
49
Growth (1Y)
27.68%
Revenue / Employee
$497,920
Profits / Employee
-$1,157,407
Market Cap
3.62B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Acadia Healthcare Company | 23,500 |
DENTSPLY SIRONA | 15,000 |
Envista Holdings | 12,800 |
Perrigo Company | 9,140 |
Option Care Health | 7,802 |
Sotera Health Company | 3,000 |
Alvotech | 999 |
Apellis Pharmaceuticals | 706 |
RYTM News
- 3 days ago - Rhythm Pharmaceuticals Announces Five Presentations at ESPE 2024, including New Real-world Data in Pediatric Patients with Acquired or Congenital Hypothalamic Obesity Treated with Setmelanotide - GlobeNewsWire
- 7 days ago - Rhythm Pharmaceuticals Announces Publication of Results from Phase 3 Study of Setmelanotide in Patients Between 2 and 5 Years Old in The Lancet Diabetes & Endocrinology - GlobeNewsWire
- 7 days ago - Rhythm Pharmaceuticals Announces New Employment Inducement Grants - GlobeNewsWire
- 15 days ago - Rhythm Pharmaceuticals Announces Participation in Upcoming Investor Conferences - GlobeNewsWire
- 15 days ago - Rhythm Pharmaceuticals, Inc. (RYTM) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 15 days ago - Rhythm Pharmaceuticals Reports Third Quarter 2024 Financial Results and Business Update - GlobeNewsWire
- 16 days ago - Rhythm Pharmaceuticals Announces Five New Data Presentations at ObesityWeek® 2024 - GlobeNewsWire
- 4 weeks ago - Rhythm Pharmaceuticals and Axovia Therapeutics Announce Joint Research Collaboration in Bardet-Biedl Syndrome - GlobeNewsWire